Asia Pacific Smart Pills Patient Monitoring Market – Size, Outlook, Trends and Forecast (2024

Asia Pacific Smart Pills Patient Monitoring Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Smart pill is a disposable capsule that can be swallowed. The capsule wirelessly transmits data. The data collected by smart pill allows the physician to evaluate the GI tract (gastrointestinal) thoroughly and it measures pressure, PH, and temperature as it travels through the gastrointestinal tract to access GI mobility. Many industries are trying to develop and integrate these technologies and advancements which will improve the market growth.

Asia-Pacific Smart Pills Patient Monitoring Market Segments size & growth:

The market is valued at $ 612.434 million in 2017 and is expected to reach $ 1511.472 million by 2024 at a CAGR of 18.9%. Smart pills patient monitoring market growth is mainly due to interest and willingness from patients to adopt this treatment methodology, easy tracking of bodily functions, raining prevalence of colon cancer and reimbursement scenario across the globe.

Asia-Pacific Smart Pills Patient Monitoring Market Share:

The market is majorly segmented into an application and is categorised into capsule endoscopy, smart pill drug delivery, patient monitoring and diagnostics. In the emerging markets, this technology is still in the seedling stage, and in future, the emerging markets are going to have the significant market share. Geographically, APAC is segmented into China, India, Japan, South Korea others. APAC is projected to grow at the highest CAGR due to increase reimbursements and huge corporate investments in R & D in developed countries like Japan.

Asia-Pacific Smart Pills Patient Monitoring Market Trends:

Novartis signed to acquire advanced accelerator applications.
Crospon acquired by Medtronic and Medtronic a global leader announced an acquisition of Covidien plc Medtronic, Inc. and Covidien plc are combined under Medtronic, plc. Are expected to begin trading on New York stock exchange.
Atmel acquired Microchip which is leading provider of microcontroller and analogue semiconductors and microchip launched products such as 8-bit, 16-bit and 32-bit featured MCU’S.

Asia-Pacific Smart Pills Patient Monitoring Market Research Report Includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players are:

Novartis AG
MicroCHIPS
Proteus pharmaceuticals
Vitality
Medtronic

globe. Asia-Pacific Smart Pills

Asia Pacific Smart Pills Patient Monitoring Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

undefinedacquired Microchip which

You can also purchase parts of this report. Do you want to check out a section wise price list

Asia Pacific Smart Pills Patient Monitoring Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.